<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>IMILIA: interpretable multiple instance learning for inflammation prediction in IBD from H&E whole slide images - Health AI Hub</title>
    <meta name="description" content="IMILIA is an end-to-end framework leveraging Multiple Instance Learning (MIL) to predict inflammation in Inflammatory Bowel Disease (IBD) from H&E whole slide i">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>IMILIA: interpretable multiple instance learning for inflammation prediction in IBD from H&E whole slide images</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.13440v1" target="_blank">2512.13440v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-15
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Thalyssa Baiocco-Rodrigues, Antoine Olivier, Reda Belbahri, Thomas Duboudin, Pierre-Antoine Bannier, Benjamin Adjadj, Katharina Von Loga, Nathan Noiry, Maxime Touzot, Hector Roux de Bezieux
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.13440v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.13440v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">IMILIA is an end-to-end framework leveraging Multiple Instance Learning (MIL) to predict inflammation in Inflammatory Bowel Disease (IBD) from H&E whole slide images. It combines a highly accurate predictive model with an interpretability module that identifies specific cell types and tissue regions driving the inflammation scores, providing biologically consistent insights. The framework demonstrates robust performance across multiple cohorts and offers a novel approach to objectively assess microscopic inflammation.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This work directly supports the shift towards histologic remission as a therapeutic target in IBD by offering an automated, objective, and interpretable tool for precise assessment of microscopic inflammation from routine pathology slides, potentially improving diagnostic accuracy, treatment monitoring, and patient outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application is the automated prediction and characterization of inflammation in Inflammatory Bowel Disease (IBD) from digital whole slide images. This can assist pathologists in more accurately and efficiently assessing disease activity, monitoring treatment response, and potentially guiding therapeutic decisions by quantifying histologic remission or inflammation levels.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical need for accurate, objective assessment of microscopic inflammation in IBD for evaluating disease activity and achieving histologic remission.</li>
                    
                    <li>Introduces IMILIA, an end-to-end framework comprising an inflammation prediction module (based on Multiple Instance Learning) and an interpretability module.</li>
                    
                    <li>The interpretability module integrates HistoPLUS for cell instance detection, segmentation, and classification, and EpiSeg for epithelium segmentation.</li>
                    
                    <li>Achieves strong predictive performance with ROC-AUCs of 0.83 on the discovery cohort and 0.99 and 0.84 on two independent external validation cohorts.</li>
                    
                    <li>Provides biologically consistent interpretability: tiles with higher predicted inflammation scores consistently exhibit increased densities of immune cells (lymphocytes, plasmocytes, neutrophils, eosinophils).</li>
                    
                    <li>Conversely, lower-scored tiles predominantly consist of normal epithelial cells, and these interpretability patterns were consistent across all datasets.</li>
                    
                    <li>Code and models are publicly available for partial replication on the IBDColEpi dataset, promoting transparency and further research.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>IMILIA is an end-to-end framework composed of two main modules. The inflammation prediction module utilizes a Multiple Instance Learning (MIL) model trained on H&E-stained whole slide images (WSIs) of IBD tissues. The interpretability module consists of two components: HistoPLUS, which performs detection, segmentation, and classification of individual cell instances (e.g., immune cells, epithelial cells), and EpiSeg, which segments epithelial regions. These components allow for the automated characterization of specific tissue regions and cell populations that drive the MIL model's inflammation predictions.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>IMILIA demonstrated strong predictive capabilities, achieving ROC-AUC scores of 0.83 on the internal discovery cohort and 0.99 and 0.84 on two distinct external validation cohorts. Crucially, the interpretability module revealed that high predicted inflammation scores consistently correlated with increased densities of various immune cell types, including lymphocytes, plasmocytes, neutrophils, and eosinophils, across all datasets. Conversely, tiles associated with lower inflammation scores were predominantly characterized by normal epithelial cells, confirming the biological consistency and validity of the model's predictions.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>IMILIA has the potential to significantly improve the standardization and objectivity of microscopic inflammation assessment in IBD, complementing or assisting pathologists. By providing an automated and interpretable tool, it could facilitate more accurate evaluation of disease activity, guide personalized treatment strategies aimed at achieving histologic remission, and reduce inter-observer variability in pathology reports. This could lead to more timely and effective therapeutic interventions, ultimately improving the quality of care and long-term outcomes for IBD patients.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the IMILIA framework or its current implementation.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly state future research directions for IMILIA, beyond making code and models publicly available for partial replication.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Gastroenterology</span>
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Digital Pathology</span>
                    
                    <span class="tag">Histopathology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Inflammatory Bowel Disease (IBD)</span>
                    
                    <span class="tag tag-keyword">Histologic Remission</span>
                    
                    <span class="tag tag-keyword">Multiple Instance Learning (MIL)</span>
                    
                    <span class="tag tag-keyword">Whole Slide Imaging (WSI)</span>
                    
                    <span class="tag tag-keyword">H&E Staining</span>
                    
                    <span class="tag tag-keyword">Inflammation Prediction</span>
                    
                    <span class="tag tag-keyword">Digital Pathology</span>
                    
                    <span class="tag tag-keyword">Interpretability</span>
                    
                    <span class="tag tag-keyword">Immune Cells</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">As the therapeutic target for Inflammatory Bowel Disease (IBD) shifts toward histologic remission, the accurate assessment of microscopic inflammation has become increasingly central for evaluating disease activity and response to treatment. In this work, we introduce IMILIA (Interpretable Multiple Instance Learning for Inflammation Analysis), an end-to-end framework designed for the prediction of inflammation presence in IBD digitized slides stained with hematoxylin and eosin (H&E), followed by the automated computation of markers characterizing tissue regions driving the predictions. IMILIA is composed of an inflammation prediction module, consisting of a Multiple Instance Learning (MIL) model, and an interpretability module, divided in two blocks: HistoPLUS, for cell instance detection, segmentation and classification; and EpiSeg, for epithelium segmentation. IMILIA achieves a cross-validation ROC-AUC of 0.83 on the discovery cohort, and a ROC-AUC of 0.99 and 0.84 on two external validation cohorts. The interpretability module yields biologically consistent insights: tiles with higher predicted scores show increased densities of immune cells (lymphocytes, plasmocytes, neutrophils and eosinophils), whereas lower-scored tiles predominantly contain normal epithelial cells. Notably, these patterns were consistent across all datasets. Code and models to partially replicate the results on the public IBDColEpi dataset can be found at https://github.com/owkin/imilia.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>